Pre-IPO Debt Restructuring: The Cleanest Way to Remove Historical Burdens

The HKEX’s Listing Committee issued a decision (HKEX LD132-2024) in Q4 2024 that tightened the scrutiny of historical debt arrangements during the vetting process. The decision explicitly warned sponsors that pre-IPO debt restructuring must demonstrate commercial substance and a clear path to permanent capital, or risk being classified as a “backdoor listing” under Practice Note 17 (PN17). This shift is not an isolated event. The SFC has, in parallel, increased its focus on “debt-for-equity swaps” and “vendor financing” structures used in the two years preceding an IPO filing, particularly where the counterparties are connected persons. For issuers carrying legacy debt from pre-2023 expansion cycles—often denominated in USD and tied to high-coupon private credit—the window to clean the balance sheet without triggering a re-listing application is narrowing. The cleanest path forward involves a structured, court-sanctioned or commercially negotiated debt restructuring executed at least 12 months before the A1 filing date, with full disclosure of the economic terms.

The Regulatory Framework: PN17 and the “Backdoor” Trigger

The HKEX’s primary concern with pre-IPO debt restructuring is that it can function as a disguised reverse takeover. Under Listing Rule 14.06B, any transaction that results in a change of control and the acquisition of assets constituting a “business” from the new controller is treated as a new listing application. A debt restructuring that converts a substantial creditor into a controlling shareholder, or that involves the issuance of a large block of shares to settle liabilities, can easily cross this threshold.

The PN17 Bright-Line Test

Practice Note 17 establishes three key tests that sponsors must apply when evaluating a restructuring. The first is the “control” test: if the debt settlement results in a single creditor or a concert party obtaining 30% or more of the issuer’s voting power, the transaction is presumed to be a reverse takeover unless the sponsor can demonstrate it is not. The second is the “asset” test: if the gross assets acquired via the debt settlement exceed 100% of the issuer’s pre-transaction asset base, the transaction is automatically classified as a very substantial acquisition (VSA) and requires a shareholder vote. The third is the “business” test: the HKEX will look at whether the restructured entity is the same business as the one described in the prospectus. If the restructuring fundamentally changes the business model or the revenue drivers, the exchange may require a fresh listing application.

The SFC’s Position on Connected Party Debt

The SFC’s Code of Conduct for Sponsors (paragraph 17.6) requires sponsors to conduct enhanced due diligence on any “significant” debt arrangements entered into within the 24 months before the listing application. This includes verifying the original use of proceeds, the identity of the ultimate beneficial owners of the lenders, and the commercial rationale for the interest rate. In a 2023 enforcement action against a Main Board applicant in the healthcare sector, the SFC found that a pre-IPO debt restructuring had been used to mask a connected loan from a director’s family trust. The sponsor was fined HKD 8 million for failing to identify the connection. The lesson is clear: sponsors must treat every pre-IPO debt instrument as a potential connected transaction until proven otherwise.

Structuring the Clean Exit: Three Viable Mechanisms

Three principal structures are available for issuers seeking to remove historical debt without triggering a re-listing. Each carries distinct implications for the listing timetable, the sponsor’s workload, and the disclosure burden.

Mechanism A: The Court-Sanctioned Scheme of Arrangement

This is the gold standard for issuers with multiple creditors and a complex capital structure. Under section 673 of the Companies Ordinance (Cap. 622), a scheme of arrangement requires approval from a majority in number representing 75% in value of each class of creditors. The scheme must be sanctioned by the Court of First Instance. The key advantage is finality: once sanctioned, the scheme binds all creditors in the class, including dissenting minority holders. For a pre-IPO issuer, this eliminates the risk of a “holdout” creditor disrupting the listing. The timetable is approximately 4-6 months from the initial application to the court order. The sponsor must, however, ensure that the scheme does not constitute a “de facto” change of control. If the scheme converts debt into equity, the sponsor must obtain a binding ruling from the HKEX under Listing Rule 2.04 that the transaction does not trigger a reverse takeover.

Mechanism B: The Bilateral Debt-for-Equity Swap

For issuers with a single or small group of institutional creditors, a bilateral swap is faster and cheaper. The issuer negotiates directly with the creditor to exchange a specified principal amount of outstanding debt for a fixed number of new shares. The key regulatory requirement under Listing Rule 7.19 is that the issue price of the shares must not be “grossly unfair” to existing shareholders. The HKEX will examine the discount to the theoretical net asset value per share. A discount exceeding 20% typically requires a shareholder waiver or a whitewash waiver under the Takeovers Code. The sponsor must also confirm that the creditor is not a “connected person” as defined under Listing Rule 1.01. If the creditor is a licensed financial institution (e.g., a bank regulated by the HKMA), the transaction is generally viewed more favorably, as the HKMA’s supervisory framework provides an independent check on the valuation.

Mechanism C: The Third-Party Debt Purchase and Capital Injection

This structure involves a third-party investor purchasing the existing debt at a discount from the original creditor and then injecting new equity into the issuer. The investor effectively “cures” the balance sheet by paying off the old debt and subscribing for new shares. The advantage is that the issuer avoids a direct negotiation with the creditor, which can be commercially sensitive. The regulatory challenge is that the HKEX will scrutinize the investor’s source of funds and its relationship with the issuer’s existing management. If the investor is a private equity fund with no prior relationship, the sponsor must demonstrate that the fund is independent and that the transaction price reflects an arm’s-length negotiation. The SFC’s guidance on “vendor financing” (SFC Circular to Sponsors, January 2022) requires the sponsor to verify that the investor has not received any side payments or indemnities from the issuer’s controlling shareholder.

The Timetable and the Sponsor’s Burden

The execution of any pre-IPO debt restructuring must be carefully sequenced to avoid delaying the listing application. The HKEX’s typical timeline for vetting a restructuring is 8-12 weeks from the date of submission of the draft prospectus. The sponsor must file a formal restructuring plan with the HKEX at least 4 weeks before the A1 submission, or risk a “stop the clock” letter.

The 12-Month Safe Harbour

A critical operational rule is the 12-month “look-back” period. If the restructuring is completed more than 12 months before the A1 filing, the HKEX will generally not require the sponsor to re-run the full due diligence on the original debt. If the restructuring is completed within 12 months of the filing, the sponsor must include a detailed “restructuring history” section in the prospectus, including the original loan agreements, the negotiation minutes, and the valuation reports for the converted shares. This adds significant cost and time. For issuers targeting a 2026 listing, the optimal window for a restructuring is therefore Q1 2025.

The Sponsor’s Due Diligence Checklist

Mayer Brown’s 2024 guidance for sponsors lists five mandatory workstreams for a pre-IPO restructuring. First, a full trace of the original loan proceeds from the creditor to the issuer’s operating subsidiaries, with bank statements. Second, a fairness opinion from an independent financial adviser on the conversion price. Third, a legal opinion from a Cayman Islands or Bermuda counsel (depending on the issuer’s domicile) confirming that the restructuring does not breach the company’s memorandum and articles of association. Fourth, a confirmation from the HKMA (if the creditor is a licensed bank) that the restructuring does not violate any prudential requirements. Fifth, a written no-objection letter from the HKEX Listing Division confirming that the restructuring does not constitute a reverse takeover.

Cross-Border Considerations: The BVI and Cayman Angle

The majority of Hong Kong-listed issuers are incorporated in the Cayman Islands or Bermuda, with operational subsidiaries in the PRC. A pre-IPO debt restructuring often involves the issuer’s BVI or Cayman holding company, which adds a layer of complexity.

The BVI Business Companies Act and Financial Assistance

Under section 60 of the BVI Business Companies Act (Cap. 213), a company is prohibited from providing financial assistance for the acquisition of its own shares unless the transaction is structured as a “solvent” buyback or redemption. A debt restructuring that involves the issuer buying back its own debt at a discount may be caught by this provision. The issuer must obtain a solvency certificate from the BVI registered agent, confirming that the company will remain solvent for the 12 months following the transaction. The sponsor must include this certificate in the due diligence file.

PRC SAFE Registration for Cross-Border Debt

If the original debt was denominated in USD and lent to a PRC operating subsidiary, the restructuring may require a filing with the State Administration of Foreign Exchange (SAFE) under the Circular on the Administration of Cross-Border Financing (SAFE Circular 16 of 2017). The conversion of foreign debt into equity in a PRC subsidiary is treated as a “debt-to-equity swap” and requires approval from the local SAFE bureau. The timeline for SAFE approval is typically 4-8 weeks. Failure to obtain this approval can result in the subsidiary being unable to remit dividends to the Hong Kong-listed holding company, which would be a material adverse change for the listing.

Actionable Takeaways for Issuers and Sponsors

1. Execute the restructuring at least 12 months before the A1 filing to avoid triggering the HKEX’s enhanced due diligence requirements and to preserve the “safe harbour” from a full re-run of the original debt review.

2. Use a court-sanctioned scheme of arrangement if the debt involves multiple creditors or a significant discount to par, as this provides finality and binds all creditors, eliminating holdout risk.

3. Obtain a binding no-objection letter from the HKEX Listing Division before completing the transaction, confirming that the restructuring does not constitute a reverse takeover under PN17.

4. Engage independent financial advisers for the fairness opinion on the conversion price, ensuring the discount to NAV is below 20% to avoid requiring a shareholder waiver or whitewash waiver.

5. Complete all cross-border regulatory filings (BVI solvency certificate, PRC SAFE registration, Cayman Islands court order) before the sponsor files the A1 application, as any pending regulatory approval will be treated as a material condition precedent.